Clinical Trials Logo

Endovascular Treatment clinical trials

View clinical trials related to Endovascular Treatment.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT06078917 Completed - Clinical trials for Endovascular Treatment

Endovascular Treatment for AIS in Chinese Municipal and County Hospitals: A "Real World" Study-ETERNITY Registry

Start date: November 1, 2021
Phase:
Study type: Observational [Patient Registry]

To investigate the Endovascular Treatment difference between Chinese city and country hospital.

NCT ID: NCT05404373 Completed - Stroke, Acute Clinical Trials

Treatment Duration on Normobaric Hyperoxia in Acute Ischemic Stroke

Start date: June 20, 2022
Phase: N/A
Study type: Interventional

Normoxia Hyperoxia (NBO) is a neuroprotective approach that can be implemented early. NBO is simple and non-invasive and can be used at home or in an ambulance to ensure the shortest possible time after cerebral ischemia occurs. The previous study by the investigators suggested that NBO therapy in the early stage of cerebral ischemia has a neuroprotective effect on ischemic brain injury. Although the neuroprotective effect of NBO has been demonstrated, the optimal duration of treatment for NBO to exert neuroprotective effect is still unclear. Therefore, further discussion of the duration of NBO treatment will contribute to the clinical application of NBO and provide a definite theoretical basis for the treatment of cerebral infarction.

NCT ID: NCT04752735 Completed - Stroke Clinical Trials

Endovascular treatmenT for Acute Ischemic Stroke in China

DETECT-China
Start date: March 22, 2021
Phase:
Study type: Observational

This is a retrospective real world registry study, aiming to explore the effectiveness and safety of endovascular treatment of acute ischemic stroke in a Chinese population.